Literature DB >> 2676237

Aspirin and other antiplatelet agents in the secondary and primary prevention of cardiovascular disease.

C H Hennekens1, J E Buring, P Sandercock, R Collins, R Peto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2676237     DOI： 10.1161/01.cir.80.4.749

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  33 in total

1.  Treating hypertension: how low is optimal and does aspirin help?

Authors:  R W Alexander
Journal:  Curr Hypertens Rep       Date:  1999 Feb-Mar       Impact factor: 5.369

Review 2.  Prevention of cardiovascular disease: risks and benefits of aspirin.

Authors:  J E Buring; C H Hennekens
Journal:  J Gen Intern Med       Date:  1990 Sep-Oct       Impact factor: 5.128

3.  Biopharmaceutical characterisation of a low-dose (75 mg) controlled-release aspirin formulation.

Authors:  W N Charman; S A Charman; D C Monkhouse; S E Frisbee; E A Lockhart; S Weisman; G A Fitzgerald
Journal:  Br J Clin Pharmacol       Date:  1993-11       Impact factor: 4.335

Review 4.  Atherosclerosis: inhibition of regression as therapeutic possibilities.

Authors:  M J Davies; D M Krikler; D Katz
Journal:  Br Heart J       Date:  1991-06

Review 5.  Treatment and prevention of cardiovascular disease by aspirin.

Authors:  C H Hennekens
Journal:  Drug Saf       Date:  1991 May-Jun       Impact factor: 5.606

6.  Periodic health examination, 1991 update: 6. Acetylsalicylic acid and the primary prevention of cardiovascular disease. Canadian Task Force on the Periodic Health Examination.

Authors: 
Journal:  CMAJ       Date:  1991-11-01       Impact factor: 8.262

7.  Effects of ezetimibe and anticoagulant combined therapy on progressing stroke: a randomized, placebo-controlled study.

Authors:  Lan Yang; Pingping Zhao; Jing Zhao; Juan Wang; Lei Shi; Xiaopeng Wang
Journal:  J Neurol       Date:  2016-09-15       Impact factor: 4.849

8.  [Not Available].

Authors:  E Hackenthal
Journal:  Schmerz       Date:  1990-09       Impact factor: 1.107

9.  Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration.

Authors: 
Journal:  BMJ       Date:  1994-01-08

Review 10.  Use of aspirin among diabetics in the primary prevention of cardiovascular disease: need for reliable randomized evidence and astute clinical judgment.

Authors:  Patricia R Hebert; Wendy R Schneider; Charles H Hennekens
Journal:  J Gen Intern Med       Date:  2009-09-22       Impact factor: 5.128
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.